JPRN-UMIN000003952已完成4 期
A multicenter, randomised, open-label study to evaluate the clinical efficacy and pharmacokinetics of oral tacrolimus (FK506) therapy under fasting and fed conditions in refractory ulcerative colitis - Oral tacrolimus (FK506) therapy under fasting and fed conditions in refractory ulcerative colitis
Department of lower gastroenterology, Hyogo College of Medicine0 个研究点目标入组 40 人开始时间: 2010年7月26日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients with severely active disease (2) Patients have undergone a colectomy (3) Patient having pregnancy or having the possibility of pregnancy (4) Patient giving the breast to a baby (5) Patient with severe renal dysfunction (6) Patient with severe liver dysfunction (7) Patient with severe infection (8) Patients with malignant disease, history of malignancy (9) Patients with past episode of severe drug allergy
研究者
相似试验
进行中（未招募）
1 期
A randomized, open-label,multi-center study to evaluate the efficacy of nilotinib versus imatinib in adult patients with gastrointestinal stromal tumors resistant to imatinib and resistant/intolerant to sunitinib - A2201Gastrointestinal stromal tumors (GIST)EUCTR2006-002267-11-BEovartis Pharma Services237
进行中（未招募）
不适用
A randomized, open-label,multi-center study to evaluate the efficacy of nilotinib versus imatinib in adult patients with gastrointestinal stromal tumors resistant to imatinib and resistant/intolerant to sunitinib - A2201EUCTR2006-002267-11-FRovartis Pharma Services246
进行中（未招募）
不适用
A randomized, open-label,multi-center study to evaluate the efficacy of nilotinib versus imatinib in adult patients with gastrointestinal stromal tumors resistant to imatinib and resistant/intolerant to sunitinib - A2201Gastrointestinal stromal tumors (GIST)EUCTR2006-002267-11-CZovartis Pharma Services210
进行中（未招募）
不适用
A randomized, open-label,multi-center study to evaluate the efficacy of nilotinib versus imatinib in adult patients with gastrointestinal stromal tumors resistant to imatinib and resistant/intolerant to sunitinib - A2201EUCTR2006-002267-11-NLovartis Pharma Services210
已完成
4 期
A randomized, open label, multicenter study to evaluate the immunogenicity and safety of BBILs trivalent type 1, 2 & 3 oral polio vaccineCTRI/2015/06/005856Bharath biotech Int Ltd200